HA
STJ

Harfst & Associates’s St Jude Medical STJ Stock Holding History

Harfst & Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-778
Closed -$57K – 338
2015
Q2 		$57K Buy
+778
New +$56.2K 0.03% 168

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Harfst & Associates's STJ Position: Q3 2015 in Review

Harfst & Associates sold out of St Jude Medical (STJ) in Q3 2015, closing a stake of 778 shares — an estimated $57K sold.

Harfst & Associates first reported a position in STJ in Q2 2015 and held it in 1 quarter. The position peaked at $57K in Q2 2015. 618 funds tracked by Wall St. Rank hold STJ as of Q3 2015.

  • Harfst & Associates reported no remaining St Jude Medical position as of Q3 2015 after selling out during the quarter.
  • Harfst & Associates sold 778 St Jude Medical shares in Q3 2015, an estimated $57K.
  • Harfst & Associates first reported a position in St Jude Medical in Q2 2015 and held it in 1 quarter.
  • Harfst & Associates's St Jude Medical position peaked at $57K in Q2 2015.
  • 618 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2015.

Based on Harfst & Associates's 13F filing for Q3 2015, filed 9 Nov 2015.